39 related articles for article (PubMed ID: 11428926)
1. Symmetry-based inhibitors of HIV protease. Structure-activity studies of acylated 2,4-diamino-1,5-diphenyl-3-hydroxypentane and 2,5-diamino-1,6-diphenylhexane-3,4-diol.
Kempf DJ; Codacovi L; Wang XC; Kohlbrenner WE; Wideburg NE; Saldivar A; Vasavanonda S; Marsh KC; Bryant P; Sham HL
J Med Chem; 1993 Feb; 36(3):320-30. PubMed ID: 8426362
[TBL] [Abstract][Full Text] [Related]
2. Three-dimensional QSAR of human immunodeficiency virus (I) protease inhibitors. 1. A CoMFA study employing experimentally-determined alignment rules.
Waller CL; Oprea TI; Giolitti A; Marshall GR
J Med Chem; 1993 Dec; 36(26):4152-60. PubMed ID: 8277496
[TBL] [Abstract][Full Text] [Related]
3. Application of the three-dimensional structures of protein target molecules in structure-based drug design.
Greer J; Erickson JW; Baldwin JJ; Varney MD
J Med Chem; 1994 Apr; 37(8):1035-54. PubMed ID: 8164249
[No Abstract] [Full Text] [Related]
4. Three-dimensional quantitative structure-activity relationship of human immunodeficiency virus (I) protease inhibitors. 2. Predictive power using limited exploration of alternate binding modes.
Oprea TI; Waller CL; Marshall GR
J Med Chem; 1994 Jul; 37(14):2206-15. PubMed ID: 8035428
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and structure-activity relationships of a series of penicillin-derived HIV proteinase inhibitors: heterocyclic ring systems containing P1' and P2' substituents.
Kitchin J; Bethell RC; Cammack N; Dolan S; Evans DN; Holman S; Holmes DS; McMeekin P; Mo CL; Nieland N
J Med Chem; 1994 Oct; 37(22):3707-16. PubMed ID: 7966131
[TBL] [Abstract][Full Text] [Related]
6. Inhibitors of HIV-1 protease containing the novel and potent (R)-(hydroxyethyl)sulfonamide isostere.
Vazquez ML; Bryant ML; Clare M; DeCrescenzo GA; Doherty EM; Freskos JN; Getman DP; Houseman KA; Julien JA; Kocan GP
J Med Chem; 1995 Feb; 38(4):581-4. PubMed ID: 7861404
[No Abstract] [Full Text] [Related]
7. A priori prediction of activity for HIV-1 protease inhibitors employing energy minimization in the active site.
Holloway MK; Wai JM; Halgren TA; Fitzgerald PM; Vacca JP; Dorsey BD; Levin RB; Thompson WJ; Chen LJ; deSolms SJ
J Med Chem; 1995 Jan; 38(2):305-17. PubMed ID: 7830273
[TBL] [Abstract][Full Text] [Related]
8. Synthetic chemical diversity: solid phase synthesis of libraries of C2 symmetric inhibitors of HIV protease containing diamino diol and diamino alcohol cores.
Wang GT; Li S; Wideburg N; Krafft GA; Kempf DJ
J Med Chem; 1995 Aug; 38(16):2995-3002. PubMed ID: 7636862
[TBL] [Abstract][Full Text] [Related]
9. HIV protease: a novel chemotherapeutic target for AIDS.
Huff JR
J Med Chem; 1991 Aug; 34(8):2305-14. PubMed ID: 1875332
[No Abstract] [Full Text] [Related]
10. Intriguing structure-activity relations underlie the potent inhibition of HIV protease by norstatine-based peptides.
Tam TF; Carrière J; MacDonald D; Castelhano AL; Pliura DH; Dewdney NJ; Thomas EM; Bach C; Barnett J; Chan H
J Med Chem; 1992 Apr; 35(7):1318-20. PubMed ID: 1560443
[No Abstract] [Full Text] [Related]
11. Penicillin derived C2-symmetric dimers as novel inhibitors of HIV-1 proteinase.
Humber DC; Cammack N; Coates JA; Cobley KN; Orr DC; Storer R; Weingarten GG; Weir MP
J Med Chem; 1992 Aug; 35(16):3080-1. PubMed ID: 1501235
[No Abstract] [Full Text] [Related]
12. Exploration of nonlinear optical properties of 4-methyl-4H-1,2,4-triazol-3-yl)thio)-N-phenylpropanamide based derivatives: experimental and DFT approach.
Irfan M; Khan HA; Bibi S; Wu G; Ali A; Khan SG; Alhokbany N; Rasool F; Chen K
Sci Rep; 2024 Feb; 14(1):2732. PubMed ID: 38302494
[TBL] [Abstract][Full Text] [Related]
13. Indol-3-ylglyoxylamide as Privileged Scaffold in Medicinal Chemistry.
Barresi E; Robello M; Baglini E; Poggetti V; Viviano M; Salerno S; Da Settimo F; Taliani S
Pharmaceuticals (Basel); 2023 Jul; 16(7):. PubMed ID: 37513909
[TBL] [Abstract][Full Text] [Related]
14. An Overview of the Biological Evaluation of Selected Nitrogen-Containing Heterocycle Medicinal Chemistry Compounds.
Ebenezer O; Jordaan MA; Carena G; Bono T; Shapi M; Tuszynski JA
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897691
[TBL] [Abstract][Full Text] [Related]
15. Classification of HIV protease inhibitors on the basis of their antiviral potency using radial basis function neural networks.
Patankar SJ; Jurs PC
J Comput Aided Mol Des; 2003; 17(2-4):155-71. PubMed ID: 13677483
[TBL] [Abstract][Full Text] [Related]
16. 4-Hydroxy-5,6-dihydropyrones as inhibitors of HIV protease: the effect of heterocyclic substituents at C-6 on antiviral potency and pharmacokinetic parameters.
Hagen SE; Domagala J; Gajda C; Lovdahl M; Tait BD; Wise E; Holler T; Hupe D; Nouhan C; Urumov A; Zeikus G; Zeikus E; Lunney EA; Pavlovsky A; Gracheck SJ; Saunders J; VanderRoest S; Brodfuehrer J
J Med Chem; 2001 Jul; 44(14):2319-32. PubMed ID: 11428926
[TBL] [Abstract][Full Text] [Related]
17. Nonpeptidic HIV protease inhibitors possessing excellent antiviral activities and therapeutic indices. PD 178390: a lead HIV protease inhibitor.
Prasad JV; Boyer FE; Domagala JM; Ellsworth EL; Gajda C; Hamilton HW; Hagen SE; Markoski LJ; Steinbaugh BA; Tait BD; Humblet C; Lunney EA; Pavlovsky A; Rubin JR; Ferguson D; Graham N; Holler T; Hupe D; Nouhan C; Tummino PJ; Urumov A; Zeikus E; Zeikus G; Gracheck SJ; Erickson JW
Bioorg Med Chem; 1999 Dec; 7(12):2775-800. PubMed ID: 10658583
[TBL] [Abstract][Full Text] [Related]
18. 4-hydroxy-5,6-dihydropyrones. 2. Potent non-peptide inhibitors of HIV protease.
Tait BD; Hagen S; Domagala J; Ellsworth EL; Gajda C; Hamilton HW; Prasad JV; Ferguson D; Graham N; Hupe D; Nouhan C; Tummino PJ; Humblet C; Lunney EA; Pavlovsky A; Rubin J; Gracheck SJ; Baldwin ET; Bhat TN; Erickson JW; Gulnik SV; Liu B
J Med Chem; 1997 Nov; 40(23):3781-92. PubMed ID: 9371244
[TBL] [Abstract][Full Text] [Related]
19. Structure-based design of HIV protease inhibitors: 5,6-dihydro-4-hydroxy-2-pyrones as effective, nonpeptidic inhibitors.
Thaisrivongs S; Romero DL; Tommasi RA; Janakiraman MN; Strohbach JW; Turner SR; Biles C; Morge RR; Johnson PD; Aristoff PA; Tomich PK; Lynn JC; Horng MM; Chong KT; Hinshaw RR; Howe WJ; Finzel BC; Watenpaugh KD
J Med Chem; 1996 Nov; 39(23):4630-42. PubMed ID: 8917652
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
